Summary Slide.png (125.32 kB)

Cost-Effectiveness of Canagliflozin Added to Standard of Care for Treating Diabetic Kidney Disease (DKD) in Patients With Type 2 Diabetes Mellitus (T2DM) in England: Estimates Using the CREDEM-DKD Model

Download (125.32 kB)
media
posted on 24.11.2020, 15:11 by Michael Willis, Andreas Nilsson, Klas Kellerborg, Philip Ball, Rupert Roe, Shana Traina, Rebecca Beale, Isabelle Newell

Article full text


The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.

History

Exports